Concepedia

Deeksha Vishwamitra

DV

Statistics

Publications

20

Citations

1.2K

H-Index

15

Active since

2012

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Baylor College of Medicine

Texas Children's Hospital

Amsterdam University Medical Centers

East China University of Science and Technology

Deeksha Vishwamitra is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and molecular oncology.

Publications per year

2012–2025

20

Publications

20

Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma

Vinod Pullarkat, Norman J. Lacayo, Elias Jabbour et al. · Cancer Discovery · 2021 · 288 citations · Full text

, , +17

Modeling Ewing sarcoma tumors in vitro with 3D scaffolds

Eliza Li Shan Fong, Salah-Eddine Lamhamedi-Cherradi, Emily Burdett et al. · Proceedings of the National Academy of Sciences · 2013 · 241 citations · Full text

, , +17

Targeting <scp>BCL</scp>‐2 with venetoclax and dexamethasone in patients with relapsed/refractory t(11;14) multiple myeloma

Jonathan L. Kaufman, Cristina Gasparetto, Fredrik Schjesvold et al. · American Journal of Hematology · 2020 · 110 citations · Full text

, , +15

Safety and activity of talquetamab in patients with relapsed or refractory multiple myeloma (MonumenTAL-1): a multicentre, open-label, phase 1–2 study

Ajai Chari, Cyrille Touzeau, Carolina Schinke et al. · The Lancet Haematology · 2025 · 83 citations · Full text

, , +12

Long-term follow-up from the phase 1/2 MajesTEC-1 trial of teclistamab in patients with relapsed/refractory multiple myeloma.

Alfred L. Garfall, Ajay K. Nooka, Niels W.C.J. van de Donk et al. · Journal of Clinical Oncology · 2024 · 77 citations

, , +16

1–5 of 20